Biohaven Ltd.
BHVN
$8.23
-$0.14-1.67%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.71% | 3.01% | -2.73% | -71.82% | -107.37% |
| Total Depreciation and Amortization | 26.31% | 34.60% | 27.03% | 29.01% | 13.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.65% | -54.90% | -67.90% | 167.71% | 432.76% |
| Change in Net Operating Assets | -91.93% | -63.38% | 891.15% | -121.58% | -31.70% |
| Cash from Operations | -4.63% | -23.34% | -34.36% | -80.80% | -75.58% |
| Capital Expenditure | 82.34% | 83.09% | 73.49% | -47.84% | -32.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 224.85% | 244.82% | -640.21% | -165.79% | -281.61% |
| Cash from Investing | 222.69% | 240.58% | -242.59% | -169.20% | -288.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -71.81% | -57.66% | -37.65% | 170.20% | 172.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,850.93% | -111.65% | 93.65% | 98.18% | 100.30% |
| Cash from Financing | -35.21% | -19.53% | 13.83% | 257.63% | 219.84% |
| Foreign Exchange rate Adjustments | -104.00% | 126.32% | 119.56% | 120.08% | 115.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.07% | 364.32% | -281.63% | -2,202.32% | -1,671.86% |